BWXT cautions that this release contains forward-looking statements, including statements relating to the production, performance, timing, impact and value of Tc-99m and changes in demand, benefit ...

They play an important role in the diagnosis of cancer patients, cardiac patients and many other conditions. Tc-99m is the decay product of longer-lived Molybdenum-99 (Mo-99) and can be made from a ...

Tc-99m is generated by NorthStar’s novel RadioGenix® System (technetium Tc 99m generator) which uses U.S.-produced, non-uranium based molybdenum-99 (Mo-99) as its source material.

BWX Technologies, Inc. announced today that it has successfully labeled technetium-99m derived from its proprietary molybdenum-99 production process and its proprietary Tc-99m generators with nine ...

ST. LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc 99m ...

The Food and Drug Administration recently announced approval of the RadioGenix™ System, a technetium 99m (Tc-99m) generator. The RadioGenix™ System is developed by NorthStar Medical ...

In continuing with this approach, the present CRP seeks to enhance the Member States capabilities for the production of Tc-99m using accelerators. The focus of this CRP is the development of ...

The FDA and the Nuclear Regulatory Agency have cleared the use of NorthStar Medical’s RadioGenix system to produce technetium-99m (Tc-99m), giving the U.S. its own source of the isotope for the ...

Nature Biotechnology - Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)–carbonyl complex Skip to main content Thank you for visiting nature.com.

Navidea Biopharmaceuticals, a company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics, has entered into an exclusive license and ...